Researchers have determined that in comparison to insulin treatment, the use of a strategy of oral glucose-lowering agents ...
Researchers have found in Phase 3 LIBerate-HoFH trial that Lerodalcibep, a third-generation PCSK9 inhibitor, showed similar ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback